CSIMarket
 


Grifols Sa  (GRFS)
Other Ticker:  
 

Grifols Sa's Leverage Ratio

GRFS's quarterly Leverage Ratio and Total Liabilities, Equity growth




GRFS Leverage Ratio (Dec 31 2020)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Equity Change -1.84 % -1.84 % -1.84 % -1.84 % 45.76 %
Y / Y Total Liabilities Change -1.63 % -1.63 % -1.63 % -1.63 % 11.78 %
Leverage Ratio MRQ 1.27 1.27 1.27 1.27 1.27
Overall Ranking # # # # #
Seq. Equity Change 0 % 0 % 0 % -1.84 % 0 %
Seq. Total Liabilities Change 0 % 0 % 0 % -1.63 % 0 %



Leverage Ratio forth quarter 2020 Comment
Due to repayements of liabilities of 0% Grifols Sa improved Leverage Ratio in forth quarter 2020 to 1.27, a new company low.

Within Major Pharmaceutical Preparations industry in the forth quarter 2020, 238 other companies have achieved lower Leverage Ratio than Grifols Sa. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are GRFS Customers?
Leverage Ratio forth quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 239
Healthcare Sector # 595
Overall Market # 2089


Leverage Ratio Statistics
High Average Low
2.01 1.55 1.27
(Dec 31 2017)   (Dec 31 2019)




Financial Statements
Grifols Sa's Equity $ 7,526 Millions Visit GRFS's Balance sheet
Grifols Sa's Total Liabilities $ 9,581 Millions Visit GRFS's Balance sheet
Source of GRFS's Sales Visit GRFS's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingDec 31 2020, within Major Pharmaceutical Preparations Industry Leverage RatioDec 31 2020 MRQ Total LiabilitiesDec 31 2020 MRQ Equity
Xeris Pharmaceuticals Inc   3.45 $ 116.517  Millions$ 33.761  Millions
Harmony Biosciences Holdings Inc   3.39 $ 329.894  Millions$ 97.180  Millions
Abvc Biopharma Inc   3.07 $ 8.168  Millions$ 2.662  Millions
Phibro Animal Health Corp  2.77 $ 590.329  Millions$ 213.322  Millions
Contrafect Corp  2.76 $ 34.892  Millions$ 12.620  Millions
Innovation Pharmaceuticals Inc   2.61 $ 8.972  Millions$ 3.436  Millions
Zoetis Inc   2.61 $ 9,840.000  Millions$ 3,773.000  Millions
Merck and Co Inc   2.57 $ 65,256.000  Millions$ 25,404.000  Millions
Collegium Pharmaceutical inc   2.41 $ 449.045  Millions$ 186.031  Millions
Apellis Pharmaceuticals inc   2.38 $ 487.157  Millions$ 204.557  Millions
Alnylam Pharmaceuticals Inc   2.35 $ 2,390.814  Millions$ 1,016.247  Millions
Rigel Pharmaceuticals Inc  2.24 $ 76.352  Millions$ 34.026  Millions
Onconova Therapeutics Inc   2.20 $ 13.585  Millions$ 6.175  Millions
Ocular Therapeutix Inc   2.17 $ 164.862  Millions$ 76.095  Millions
Bristol Myers Squibb Co  2.13 $ 80,659.000  Millions$ 37,882.000  Millions
Tricida Inc   2.09 $ 227.689  Millions$ 108.871  Millions
Insmed Inc  1.89 $ 520.271  Millions$ 275.884  Millions
Bridgebio Pharma Inc   1.87 $ 199.219  Millions$ 106.256  Millions
Adhera Therapeutics Inc   1.86 $ 4,775.375  Millions$ 2,561.375  Millions
Ionis Pharmaceuticals Inc   1.83 $ 1,546.408  Millions$ 843.347  Millions
Mei Pharma Inc   1.77 $ 130.382  Millions$ 73.498  Millions
Morphosys Ag  1.67 $ 1,162.774  Millions$ 695.881  Millions
China Pharma Holdings Inc   1.64 $ 13.113  Millions$ 8.005  Millions
Prestige Consumer Healthcare Inc   1.62 $ 2,145.548  Millions$ 1,323.221  Millions
Akebia Therapeutics Inc   1.60 $ 396.521  Millions$ 247.618  Millions
Fresenius Medical Care Ag and Co Kgaa  1.57 $ 21,680.653  Millions$ 13,811.067  Millions
Viatris Inc   1.55 $ 35,475.200  Millions$ 22,954.100  Millions
Epizyme Inc   1.54 $ 284.011  Millions$ 184.897  Millions
Prophase Labs Inc   1.51 $ 15.956  Millions$ 10.556  Millions
Vyne Therapeutics Inc   1.50 $ 56.249  Millions$ 37.493  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HHLA's Profile

Stock Price

HHLA's Financials

Business Description

Fundamentals

Charts & Quotes

HHLA's News

Suppliers

HHLA's Competitors

Customers & Markets

Economic Indicators

HHLA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071